OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Cost-Effectiveness of Low-Cost Essential Antihypertensive Medicines for Hypertension Control in China: A Modelling Study
Dongfeng Gu, Jiang He, Pamela G. Coxson, et al.
PLoS Medicine (2015) Vol. 12, Iss. 8, pp. e1001860-e1001860
Open Access | Times Cited: 85

Showing 26-50 of 85 citing articles:

Cost-effectiveness analysis of intensive hypertension control in China
Xiaolei Xie, Tianhua He, Jian Kang, et al.
Preventive Medicine (2018) Vol. 111, pp. 110-114
Closed Access | Times Cited: 28

Applicability and cost-effectiveness of the Systolic Blood Pressure Intervention Trial (SPRINT) in the Chinese population: A cost-effectiveness modeling study
Chao Li, Kangyu Chen, Victoria Cornelius, et al.
PLoS Medicine (2021) Vol. 18, Iss. 3, pp. e1003515-e1003515
Open Access | Times Cited: 21

Cost-Effectiveness of Improved Hypertension Management in India through Increased Treatment Coverage and Adherence: A Mathematical Modeling Study
Hemanshu Das, Andrew E. Moran, Anupam Khungar Pathni, et al.
Global Heart (2021) Vol. 16, Iss. 1, pp. 37-37
Open Access | Times Cited: 20

Cost-effectiveness of treatment in adults with blood pressure of 130–139/80–89 mmHg and high cardiovascular risk in China: a modelling study
Jiangtao Li, Dong Zhao, Jun Cai, et al.
The Lancet Regional Health - Western Pacific (2023) Vol. 42, pp. 100962-100962
Open Access | Times Cited: 8

Health system strengthening and hypertension management in China
Kehui Huang, Yu Ting Song, Yong He, et al.
Global Health Research and Policy (2016) Vol. 1, Iss. 1
Open Access | Times Cited: 23

The burden, management rates and influencing factors of high blood pressure in a Chinese rural population: the Rural Diabetes, Obesity and Lifestyle (RuralDiab) study
Xiaotian Liu, Yuqian Li, Ying Guo, et al.
Journal of Human Hypertension (2018) Vol. 32, Iss. 3, pp. 236-246
Closed Access | Times Cited: 21

Blood Pressure and Risk of Subarachnoid Hemorrhage in China
Iain McGurgan, Robert Clarke, Ben Lacey, et al.
Stroke (2018) Vol. 50, Iss. 1, pp. 38-44
Open Access | Times Cited: 20

Cost-effectiveness of folic acid therapy for primary prevention of stroke in patients with hypertension
Tiantian Zhang, Zhuoru Liang, Tengfei Lin, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 11

Trends and Inequalities in the Health Care and Hypertension Outcomes in China, 2011 to 2015
Yang Zhao, Ajay Mahal, Tilahun Haregu, et al.
International Journal of Environmental Research and Public Health (2019) Vol. 16, Iss. 22, pp. 4578-4578
Open Access | Times Cited: 16

Age–Period–Cohort Analysis of Long Trend of Mortality for Stroke and Subtypes Attributed to High SBP in Chinese Adults
Yudiyang Ma, Jinhong Cao, Sumaira Mubarik, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 10

Hypertension in China
Jiang He
Journal of Hypertension (2015) Vol. 34, Iss. 1, pp. 29-31
Closed Access | Times Cited: 15

Temporal Trends and Geographic Disparity in Hypertension Care in China
Yang Zhao, Brian Oldenburg, Siqi Zhao, et al.
Journal of Epidemiology (2019) Vol. 30, Iss. 8, pp. 354-361
Open Access | Times Cited: 15

Administration time-dependent effects of combination therapy on ambulatory blood pressure in hypertensive subjects.
Weizhong Huangfu, Peilin Duan, Dingcheng Xiang, et al.
PubMed (2015) Vol. 8, Iss. 10, pp. 19156-61
Closed Access | Times Cited: 14

Socioeconomic Status and Its Relation to Hypertension in Rural Nepal
Sanju Bhattarai, Birgit J. Tandstad, Archana Shrestha, et al.
International Journal of Hypertension (2021) Vol. 2021, pp. 1-9
Open Access | Times Cited: 12

Economic evaluation of olmesartan/amlodipine fixed-dose combination for hypertension treatment in China
Maodong Ren, Dennis Xuan, Yongji Lu, et al.
Journal of Medical Economics (2019) Vol. 23, Iss. 4, pp. 394-400
Open Access | Times Cited: 13

Access to Antihypertensive Drugs in China
Ge Bai, Catherine Bennet, Ji‐Guang Wang, et al.
Circulation (2018) Vol. 138, Iss. 17, pp. 1777-1779
Open Access | Times Cited: 12

Cost-effectiveness of hypertension therapy based on 2020 International Society of Hypertension guidelines in Ethiopia from a societal perspective
Majid Davari, Mende Mensa Sorato, Abbas Kebriaeezadeh, et al.
PLoS ONE (2022) Vol. 17, Iss. 8, pp. e0273439-e0273439
Open Access | Times Cited: 7

Hypertension: A Continuing Public Healthcare Issue
Samaneh Goorani, Somaye Zangene, John D. Imig
International Journal of Molecular Sciences (2024) Vol. 26, Iss. 1, pp. 123-123
Open Access | Times Cited: 1

Burden of cardiovascular diseases associated with fine particulate matter in Beijing, China: an economic modelling study
Yawen Jiang, Shan Jiang, Weiyi Ni
BMJ Global Health (2020) Vol. 5, Iss. 10, pp. e003160-e003160
Open Access | Times Cited: 8

Scroll to top